Axios on MSN
Longevity medicine's do-or-die moment
The world's first human trial of whether a drug can essentially make a person's cells younger sets up a reality check for one ...
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
Reversing cellular age isn’t science fiction, but the biology is more complicated than either the skeptics or the hype ...
The Amazing Times on MSN
World's first reverse-aging drug was just injected in a human
A groundbreaking discovery led scientists to create a world's first - a drug that can reverse the signs of biological aging.
Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic editing platform that enables safe modification of multiple genes in primary ...
The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...
People with obesity and type 2 diabetes are at high risk of blood vessel damage. This risk depends not only on the genes a ...
Researchers developed an OSK therapy that can partially reset epigenetic aging in optic neurons. Preclinical data ...
Lactate, once considered a metabolic waste product, is now recognized as a key regulator of cellular homeostasis and disease progression. In gynecological malignancies-including ovarian, cervical, and ...
As AI transforms biology, longevity startups are attracting investors, advancing toward clinical milestones, and reshaping ...
In the cancer type multiple myeloma, the malignant cells differ significantly from normal cells regarding the layer of chemical "tags" on DNA and proteins that control whether genes are turned on or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results